Skip to main content
Erschienen in: Neurological Sciences 6/2019

27.02.2019 | Original Article

Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease

verfasst von: Elisa Conti, Denise Grana, Giovanni Stefanoni, Alberto Corsini, Margherita Botta, Paolo Magni, Angelo Aliprandi, Christian Lunetta, Ildebrando Appollonio, Carlo Ferrarese, Lucio Tremolizzo

Erschienen in: Neurological Sciences | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Behavioral dysfunctions (BPSD) represent the most important problem in Alzheimer’s dementia (AD) management. We assessed the serum levels of two myokines in AD patients, preliminary investigating, as secondary aim, their role as potential biomarkers for agitation/aggression (AA) and aberrant motor behavior (AMB): irisin, since it is able to modify the motor pattern, and BDNF, since it was transcribed following irisin stimulation. Forty AD patients were recruited and characterized according to the expressed neuropsychiatric syndrome. Myokines were measured by ELISA. Irisin serum levels were slightly elevated in AA+ patients (+ 10.0%; p < 0.05) and correlated with the duration of AA (r = 0.74, p < 0.03). BDNF failed to show such differences. We propose that these selected myokines are not useful as surrogate markers for agitation in AD, but might represent interesting secondary outcomes when testing drugs for those BPSD implying elevated motor activity.
Literatur
1.
Zurück zum Zitat Zdanys KF, Carvalho AF, Tampi RR, Steffens DC (2016) The treatment of behavioral and psychological symptoms of dementia: weighing benefits and risks. Curr Alzheimer Res 13:1124–1133CrossRefPubMed Zdanys KF, Carvalho AF, Tampi RR, Steffens DC (2016) The treatment of behavioral and psychological symptoms of dementia: weighing benefits and risks. Curr Alzheimer Res 13:1124–1133CrossRefPubMed
2.
Zurück zum Zitat Tremolizzo L, Tironi M, Ferrarese C, Appollonio I (2013) Neuroleptic equivalent dose differences and behavioral and psychological symptoms of dementia. Dement Geriatr Cogn Disord 35:118–120CrossRefPubMed Tremolizzo L, Tironi M, Ferrarese C, Appollonio I (2013) Neuroleptic equivalent dose differences and behavioral and psychological symptoms of dementia. Dement Geriatr Cogn Disord 35:118–120CrossRefPubMed
3.
Zurück zum Zitat Bloniecki V, Aarsland D, Cummings J, Blennow K, Freund-Levi Y (2014) Agitation in dementia: relation to core cerebrospinal fluid biomarker levels. Dement Geriatr Cogn Dis Extra 4:335–343CrossRefPubMedPubMedCentral Bloniecki V, Aarsland D, Cummings J, Blennow K, Freund-Levi Y (2014) Agitation in dementia: relation to core cerebrospinal fluid biomarker levels. Dement Geriatr Cogn Dis Extra 4:335–343CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R (1998) Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry 44:918–921CrossRefPubMed Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R (1998) Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry 44:918–921CrossRefPubMed
5.
Zurück zum Zitat Higuchi M, Hatta K, Honma T, Hitomi YH, Kambayashi Y, Hibino Y, Matsuzaki I, Sasahara S, Nakamura H (2010) Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease. Int J Geriatr Psychiatry 25:604–611PubMed Higuchi M, Hatta K, Honma T, Hitomi YH, Kambayashi Y, Hibino Y, Matsuzaki I, Sasahara S, Nakamura H (2010) Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease. Int J Geriatr Psychiatry 25:604–611PubMed
6.
Zurück zum Zitat Zhang W, Chang L, Zhang C, Zhang R, Li Z, Chai B, Li J, Chen E, Mulholland M (2015) Irisin: a myokine with locomotor activity. Neurosci Lett 595:7–11CrossRefPubMedPubMedCentral Zhang W, Chang L, Zhang C, Zhang R, Li Z, Chai B, Li J, Chen E, Mulholland M (2015) Irisin: a myokine with locomotor activity. Neurosci Lett 595:7–11CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index. Peptides 39:125–130CrossRefPubMed Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index. Peptides 39:125–130CrossRefPubMed
8.
Zurück zum Zitat Jodeiri Farshbaf M, Ghaedi K, Megraw TL, Curtiss J, Shirani Faradonbeh M, Vaziri P, Nasr-Esfahani MH (2016) Does PGC1α/FNDC5/BDNF elicit the beneficial effects of exercise on neurodegenerative disorders? NeuroMolecular Med 18:1–15CrossRefPubMed Jodeiri Farshbaf M, Ghaedi K, Megraw TL, Curtiss J, Shirani Faradonbeh M, Vaziri P, Nasr-Esfahani MH (2016) Does PGC1α/FNDC5/BDNF elicit the beneficial effects of exercise on neurodegenerative disorders? NeuroMolecular Med 18:1–15CrossRefPubMed
10.
Zurück zum Zitat Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, DeStefano AL, Vasan RS, Seshadri S (2014) Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol 71:55–61CrossRefPubMedPubMedCentral Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, DeStefano AL, Vasan RS, Seshadri S (2014) Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol 71:55–61CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Küster OC, Laptinskaya D, Fissler P, Schnack C, Zügel M, Nold V, Thurm F, Pleiner S, Karabatsiakis A, von Einem B, Weydt P, Liesener A, Borta A, Woll A, Hengerer B, Kolassa IT, von Arnim CAF (2017) Novel blood-based biomarkers of cognition, stress, and physical or cognitive training in older adults at risk of dementia: preliminary evidence for a role of BDNF, irisin, and the kynurenine pathway. J Alzheimers Dis 59:1097–1111CrossRefPubMed Küster OC, Laptinskaya D, Fissler P, Schnack C, Zügel M, Nold V, Thurm F, Pleiner S, Karabatsiakis A, von Einem B, Weydt P, Liesener A, Borta A, Woll A, Hengerer B, Kolassa IT, von Arnim CAF (2017) Novel blood-based biomarkers of cognition, stress, and physical or cognitive training in older adults at risk of dementia: preliminary evidence for a role of BDNF, irisin, and the kynurenine pathway. J Alzheimers Dis 59:1097–1111CrossRefPubMed
12.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939–944CrossRefPubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939–944CrossRefPubMed
13.
Zurück zum Zitat Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, Canonico V, Trequattrini A, Pettenati C, Caltagirone C, Palmer K (2010) Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry 18:1026–1035CrossRefPubMed Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, Canonico V, Trequattrini A, Pettenati C, Caltagirone C, Palmer K (2010) Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry 18:1026–1035CrossRefPubMed
14.
Zurück zum Zitat van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P (2007) Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 23:42–46CrossRefPubMed van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P (2007) Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 23:42–46CrossRefPubMed
15.
Zurück zum Zitat Conti E, Tremolizzo L, Santarone ME, Tironi M, Radice I, Zoia CP, Aliprandi A, Salmaggi A, Dominici R, Casati M, Appollonio I, Ferrarese C (2016) Donepezil modulates the endogenous immune response: implications for Alzheimer's disease. Hum Psychopharmacol 31:296–303CrossRefPubMed Conti E, Tremolizzo L, Santarone ME, Tironi M, Radice I, Zoia CP, Aliprandi A, Salmaggi A, Dominici R, Casati M, Appollonio I, Ferrarese C (2016) Donepezil modulates the endogenous immune response: implications for Alzheimer's disease. Hum Psychopharmacol 31:296–303CrossRefPubMed
16.
Zurück zum Zitat Tremolizzo L, Pellegrini A, Conti E, Arosio A, Gerardi F, Lunetta C, Magni P, Appollonio I, Ferrarese C (2016) BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis. Neurodegener Dis 16:192–198CrossRefPubMed Tremolizzo L, Pellegrini A, Conti E, Arosio A, Gerardi F, Lunetta C, Magni P, Appollonio I, Ferrarese C (2016) BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis. Neurodegener Dis 16:192–198CrossRefPubMed
17.
Zurück zum Zitat Nagels G, Engelborghs S, Vloeberghs E, Van Dam D, Pickut BA, De Deyn PP (2006) Actigraphic measurement of agitated behaviour in dementia. Int J Geriatr Psychiatry 21:388–393CrossRefPubMed Nagels G, Engelborghs S, Vloeberghs E, Van Dam D, Pickut BA, De Deyn PP (2006) Actigraphic measurement of agitated behaviour in dementia. Int J Geriatr Psychiatry 21:388–393CrossRefPubMed
18.
Zurück zum Zitat Mahlberg R, Walther S (2007) Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. Z Gerontol Geriatr 40:178–184CrossRefPubMed Mahlberg R, Walther S (2007) Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. Z Gerontol Geriatr 40:178–184CrossRefPubMed
19.
Zurück zum Zitat Phillips C, Baktir MA, Srivatsan M, Salehi A (2014) Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Front Cell Neurosci 8:170CrossRefPubMedPubMedCentral Phillips C, Baktir MA, Srivatsan M, Salehi A (2014) Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Front Cell Neurosci 8:170CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Arosio A, Sala G, Rodriguez-Menendez V, Grana D, Gerardi F, Lunetta C, Ferrarese C, Tremolizzo L (2016) MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. Mol Cell Neurosci 74:10–17CrossRefPubMed Arosio A, Sala G, Rodriguez-Menendez V, Grana D, Gerardi F, Lunetta C, Ferrarese C, Tremolizzo L (2016) MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. Mol Cell Neurosci 74:10–17CrossRefPubMed
21.
Zurück zum Zitat Lunetta C, Lizio A, Tremolizzo L, Ruscica M, Macchi C, Riva N, Weydt P, Corradi E, Magni P, Sansone V (2018) Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status. J Neurol 265:3001–3008CrossRefPubMed Lunetta C, Lizio A, Tremolizzo L, Ruscica M, Macchi C, Riva N, Weydt P, Corradi E, Magni P, Sansone V (2018) Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status. J Neurol 265:3001–3008CrossRefPubMed
Metadaten
Titel
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease
verfasst von
Elisa Conti
Denise Grana
Giovanni Stefanoni
Alberto Corsini
Margherita Botta
Paolo Magni
Angelo Aliprandi
Christian Lunetta
Ildebrando Appollonio
Carlo Ferrarese
Lucio Tremolizzo
Publikationsdatum
27.02.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 6/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03781-y

Weitere Artikel der Ausgabe 6/2019

Neurological Sciences 6/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.